This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain
Theatre (OTs) dedicated to cataract, LASIK, and retina treatments added to meet the growing demand
ALPLA is going to manufacture high-quality plastic bottles, preforms, matching closures and injection-molded parts in Chachoengsao using all core technologies
EMBLAVEOTM is the first and only monobactam/?-lactamase inhibitor combination antibiotic therapy approved by the USFDA
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME)
Novel illumination system with key components molded in Radel® PPSU for durability and repeated sterilization
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
PROVIGIL and NUVIGIL are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy
The new brand name reflects the evolution from a generics-focused Contract Research Organization (CRO) to a drug development services enterprise
Parents, teachers, and caregivers play a vital role in spotting early signs of schizophrenia
Subscribe To Our Newsletter & Stay Updated
